Healthy volunteers test new drug forms in early safety trial
NCT ID NCT05727189
First seen Mar 19, 2026 · Last updated May 13, 2026 · Updated 11 times
Summary
This early-stage study tests the safety and how the body processes three different forms of an experimental drug called idazoxan in 150 healthy adults. Participants take a single dose and are monitored for side effects and drug levels in the blood. The goal is to gather safety data, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX Clinical Research
Adelaide, South Australia, 5000, Australia
-
Scientia Clinical Research
Randwick, New South Wales, 2031, Australia
Conditions
Explore the condition pages connected to this study.